Home/Filings/4/0001606498-25-000034
4//SEC Filing

James Mojirade 4

Accession 0001606498-25-000034

CIK 0001606498other

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 2:25 PM ET

Size

8.4 KB

Accession

0001606498-25-000034

Insider Transaction Report

Form 4
Period: 2025-03-04
James Mojirade
SVP, General Counsel
Transactions
  • Exercise/Conversion

    Common Stock

    2025-03-04+8,03978,352 total
  • Tax Payment

    Common Stock

    2025-03-04$15.13/sh2,636$39,88375,716 total
  • Tax Payment

    Common Stock

    2025-03-04$15.13/sh2,068$31,28973,648 total
Footnotes (3)
  • [F1]Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each PRSU is the economic eqiuvalent of one share of Common Stock.
  • [F2]Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 8,039 PRSUs which vested on March 4, 2025.
  • [F3]Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 6,880 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each TRSU is the economic equivalent of one share of Common Stock.

Issuer

AVANOS MEDICAL, INC.

CIK 0001606498

Entity typeother

Related Parties

1
  • filerCIK 0001872825

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 2:25 PM ET
Size
8.4 KB